Tau protein and Alzheimers disease

Chinese Pharmacological Bulletin

Volumn 20, Issue 6, 2004, Pages 601-605

  Peng, Ying ^a   Wang, Xiao Liang ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Alzheimers disease; Hyperphosphorylation; Neurofibrillary tangle; Tau protein; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE; TAU KINASE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; HUMAN; NERVE CELL NECROSIS; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 4043063502     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alafuzoff I, Iqbal K, Friden H et al. Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl), 1987;74(3):209-25
2. Lee VM-Y, Balin BJ, Otvos L et al. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science, 1991;251(4994):675-8
3. Lee G, Neve RL, Kosik KS. The microtubule binding domain of tau protein. Neuron, 1989;2(6):1615-24
4. Johnson GV, Bailey CD. Tau, where are we now? J Alzheimers Dis, 2002;4(5):375-98
5. Kanai Y, Takemura R, Oshima T et al. Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA. J Cell Biol, 1989;109(3): 1173-84
6. Biernat J, Gustke N, Drewes G et al. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding. Neuron, 1993;11(1):153-63
7. Shahani N, Brandt R. Functions and malfunctions of the tau proteins. Cell Mol Life Sci, 2002;59(10):1668-80
8. Blennow K, Vanmechelen E, Hampel H. CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease. Mol Neurobiol, 2001;24(1-3):87-97
9. Kopke E, Tung YC, Shaikh S et al. Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease. J Biol Chem, 1993;268 (32):24374-84
10. Maccioni RB, Munoz JP, Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res, 2001;32(5):367-81
11. Eldar-Finkelman H. Glycogen synthase kinase 3: An emerging therapeutic target. Trends Mol Med, 2002;8(3):126-32
12. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol, 2001; 65(4):1391-426
13. Sang H, Lu Z, Li Y et al. Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules. Neurosci Lett, 2001;312(3):141-4
14. Pei JJ, Braak E, Braak H et al. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol, 1999;58(9):1010-19
15. Garrido JL, Godoy JA, Alvarez A et al. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J, 2002;16(14):1982-4
16. Patrick GN, Zukerberg L, Mikolic M et al. Conversion of p35 to p25 deregulates cdk5 activity and promotes neurodegeneration. Nature, 1999;401(6762):615-22
17. Wang JZ, Gong CX, Zaidi T et al. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and-2B. J Biol Chem, 1995;270(9):4854-60
18. Gong CX, Lidsky T, Wegiel J et al. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem, 2000;275(8):5535-44
19. Rapoport M, Dawson HN, Binder LI et al. Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA, 2002;99(9):6364-9
20. Lewis J, Dickson DW, Lin WL et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science, 2001;293(5534):1487- 91
21. Götz J, Chen F, Dorpe J et al. Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils. Science, 2001;293(5534):1491-5
22. Gold M. Tau therapeutics for Alzheimer's disease: The promise and the challenges. J Mol Neurosci, 2002;19(3):331-4
23. Mary LM. Drugs targeting Alzheimer's disease: Some things old and some things new. J Pharmaco and Experimental Therapeutics, 2003;304(3):897-903
24. Michaelis ML, Dobrowsky RT, Li G. Tau neurafibrillary pathology and microtubule stability. J Mol Neurosci, 2002;19 (3):289-93